SCHEMBL6003036

SCHEMBL6003036

COc1ccccc1C(O)c1c(OC)cccc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.48
CA2 P00918 3/20 0.48
CA12 O43570 2/20 0.48
CA7 P43166 2/20 0.48
CA9 Q16790 2/20 0.48
CA14 Q9ULX7 2/20 0.48
CA4 P22748 1/20 0.48
CHRM2 P08172 1/20 0.47
CHRM4 P08173 1/20 0.47
CHRM5 P08912 1/20 0.47
CHRM1 P11229 1/20 0.47
CHRM3 P20309 1/20 0.47
ACHE P22303 1/20 0.46
TP53 P04637 2/20 0.45
TSHR P16473 1/20 0.45
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7122164 0.87 CA1 (0.50) CA1CA2CA12CA7CA9
SCHEMBL238441 0.87 CA1 (0.57) CA1CA2CA12CA7CA9
SCHEMBL18550495 0.80 ALDH1A1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL7259231 0.80 CA1 (0.60) CA1CA2CA12CA7CA9
SCHEMBL30273872 0.79 IDO1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL477540 0.79 IDO1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL30986735 0.79 IDO1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL3862578 0.79 IDO1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL30476555 0.79 IDO1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL23084671 0.78 CA1 (0.57) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed